Reported 8 months ago
In the midst of the COVID-19 outbreak, a Taiwanese-founded company, Ruichim Biotechnology, created a groundbreaking technology using digital bio-barcode (BMB) to rapidly test various infections and allergens with a small amount of bodily fluid, potentially even detecting cancer in the future. This contrasts with the infamous story of Elizabeth Holmes, the youngest female billionaire, who founded Theranos and misled investors with false promises of blood testing capabilities. Unlike Theranos, Ruichim Biotechnology's success lies in their expertise in semiconductor technology and Taiwan's robust supply chain, emphasizing the importance of interdisciplinary knowledge and industry collaboration in developing innovative biotech products.
Source: YAHOO